Evaluation of Omega Roll Envelope Flap for Soft Tissue Augmentation Around Osseointegrated Dental Implants
NCT ID: NCT06091605
Last Updated: 2023-10-19
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
PHASE4
24 participants
INTERVENTIONAL
2023-11-01
2025-05-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Aim of the study: The aim of this study will be to evaluate the efficacy of the Omega roll envelope flap (OREF) technique compared to the conventional envelope split-thickness flap technique combined with an autogenous connective tissue graft, in enhancing Peri-implant soft tissue phenotype defined by the gingival thickness, keratinized tissue width, mucosal margin level and interproximal papilla height around implant.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Efficacy of a Ready Made Plastic Stent With Apically Repositioned Flap in Augmentation of the Peri Implant Soft Tissue
NCT03754894
Midfacial Gingival Margin Changes Following Immediate Implants.
NCT05975515
Efficacy of Collagen Matrix for Peri-implant Soft Tissue Phenotype Modification
NCT07056959
Comparison of Peri Implant Soft Tissue Esthetics With Immediate Temporization With and Without Subepithelial Connective Tissue Graft
NCT03770975
Effect of Different Suture Techniques on Early Healing of Peri-implant Soft Tissue
NCT05289635
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Omega roll envelope flap (OREF) technique
Patients will undergo peri-implant soft tissue augmentation procedures accompanied by the placement of healing abutments at the uncovering of the inserted osseo-integrated implants, 12 weeks after the initial stage of implant placement.
Omega roll envelope flap (OREF) technique will be done around the placed healing abutment, then suturing will be done.
Soft tissue augmentation around dental implants.
Soft tissue augmentation around dental implants using Omega roll envelope flap (OREF) technique.
Envelope flap combined with a sub-epithelial connective tissue graft
Patients will undergo peri-implant soft tissue augmentation procedures accompanied by the placement of healing abutments at the uncovering of the inserted osseo-integrated implants, 12 weeks after the initial stage of implant placement.
An envelope split thickness flap will be made at the concerned implant site and a connective tissue graft will be harvested from the tuberosity and then adapted to the placed healing abutment at the surgical site and suturing will be done.
Soft tissue augmentation around dental implants.
Soft tissue augmentation around dental implants using Omega roll envelope flap (OREF) technique.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Soft tissue augmentation around dental implants.
Soft tissue augmentation around dental implants using Omega roll envelope flap (OREF) technique.
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
18 Years
50 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Ain Shams University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Amr Mohamed Saeed Abd El Aziz
Phd Researcher
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Mohamed S Abd El Aziz
Role: CONTACT
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
FD-ASU1255
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.